New research highlights the Pictor PictVet Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to enhance global ...
11d
Pictor's Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle
Mycoplasma bovis is a devastating pathogen that threatens cattle health and productivity worldwide. In the United States ...
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the ...
The CDC’s standard two-tier Lyme diagnostic misses the majority of early cases, delaying treatment and increasing the risk of developing persistent, debilitating symptoms for patients. The two novel ...
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development.
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
Background PSA-directed prostate cancer screening leads to a high rate of false positive identifications and an unnecessary biopsy burden. Epigenetic biomarkers have proven useful, exhibiting frequent ...
VENLO, Netherlands--(BUSINESS WIRE)--$QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback